+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Influenza Diagnostics Market 2019-2023 - Product Image

Global Influenza Diagnostics Market 2019-2023

  • ID: 4801837
  • Report
  • July 2019
  • Region: Global
  • 143 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • MORE
Global Influenza Diagnostics Market: About this market

Influenza diagnostic kits are available in both rapid and conventional testing models. These kits can detect influenza virus strains in swab samples collected from the nasal, nasopharyngeal, or oropharyngeal region. This influenza diagnostics market analysis considers sales from point-of-care testing, immunodiagnostics, and molecular diagnostics kits segments to end-user sectors such as hospitals and diagnostic laboratories, academic and research institutions, and home care. Our analysis also considers the sales of influenza diagnostics in Asia, Europe, North America, and ROW. In 2018, the point-of-care testing segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the rising need for rapid influenza testing in outpatient and home care settings and in physician-owned laboratories will significantly help the point-of-care testing segment in maintaining its leading market position. Also, our global Influenza diagnostics report has observed market growth factors such as the increasing demand for point-of-care diagnostics, rising focus on the prevention of pandemic influenza, and high demand for influenza diagnostics during seasonal prevalence. However, challenges such as the lack of laboratory infrastructure in developing regions, consistent development of new diagnostic procedures for emerging influenza virus, and stringent compliance and regulatory requirements may hamper the growth of the Influenza diagnostics industry over the forecast period.

Global Influenza Diagnostics Market: Overview

Increasing demand for point-of-care diagnostics

The rising need for quick influenza monitoring and the lack of healthcare infrastructure in developing countries are increasing the need for point-of-care diagnostics, which provide rapid results. The quick antigen detection ability of rapid influenza diagnostics tests (RIDTs) help healthcare practitioners in providing timely and appropriate treatment. These factors are increasing the sales of RIDT kits, which are point-of-care products. Vendors are further focusing on improving their efficacy and precision. As a result, the market is expected to record a CAGR of almost 6% during the forecast period.

Increasing approvals of influenza diagnostic products by regulatory authorities

Key market vendors have been upgrading their products to meet compliance standards set by authorities such as the US FDA, CFDA, and ECDC. Consequently, the number of approvals is increasing. As a result, many influenza detection kits are commercially available. The sales of these kits will continue to rise owing to the growing incidence of influenza cases across the world, which will augment sales. Therefore, the increasing approvals of influenza diagnostic products by regulatory authorities will have a positive impact on the overall market growth.

Competitive Landscape

With the presence of several major players, the global influenza diagnostics market is moderately fragmented. This robust vendor analysis is designed to help clients in improving their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics producers, which include Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc.

Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: SEGMENTATION BY END-USER

PART 07: SEGMENTATION BY INDICATION

PART 08: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Point-of-care testing - Market size and forecast 2018-2023
  • Immunodiagnostics - Market size and forecast 2018-2023
  • Molecular diagnostics - Market size and forecast 2018-2023
  • Market opportunity by product
PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Surge in number of genetic characterization studies on influenza virus
  • Increasing approvals of influenza diagnostic products by regulatory authorities
  • Rising adoption of rapid diagnostic products in physician office laboratories
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Thermo Fisher Scientific Inc.
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Years in consideration
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market characteristics analysis
Exhibit 06: Market segments
Exhibit 07: Market definition - Inclusions and exclusions checklist
Exhibit 08: Market size 2018
Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 11: Five forces analysis 2018
Exhibit 12: Five forces analysis 2023
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2018
Exhibit 19: Influenza A diagnostic product in commercial market space:
Exhibit 20: Product - Market share 2018-2023 (%)
Exhibit 21: Comparison by product
Exhibit 22: Point-of-care testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Point-of-care testing - Year-over-year growth 2019-2023 (%)
Exhibit 24: Immunodiagnostics - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Immunodiagnostics - Year-over-year growth 2019-2023 (%)
Exhibit 26: Molecular diagnostics - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Molecular diagnostics - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Customer landscape analysis
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Decision framework
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Exhibit: Nucleic acid detection-based US FDA-cleared influenza diagnostics test in commercial market (as of 2019)
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendor landscape analysis
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Abbott Laboratories - Vendor overview
Exhibit 53: Abbott Laboratories - Business segments
Exhibit 54: Abbott Laboratories - Organizational developments
Exhibit 55: Abbott Laboratories - Geographic focus
Exhibit 56: Abbott Laboratories - Segment focus
Exhibit 57: Abbott Laboratories - Key offerings
Exhibit 58: bioMérieux SA - Vendor overview
Exhibit 59: bioMérieux SA - Business segments
Exhibit 60: bioMérieux SA - Organizational developments
Exhibit 61: bioMérieux SA - Geographic focus
Exhibit 62: bioMérieux SA - Key offerings
Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 64: Bio-Rad Laboratories Inc. - Business segments
Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 69: Danaher Corp. - Vendor overview
Exhibit 70: Danaher Corp. - Business segments
Exhibit 71: Danaher Corp. - Organizational developments
Exhibit 72: Danaher Corp. - Geographic focus
Exhibit 73: Danaher Corp. - Segment focus
Exhibit 74: Danaher Corp. - Key offerings
Exhibit 75: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 76: Thermo Fisher Scientific Inc. - Business segments
Exhibit 77: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 78: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 79: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 80: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 81: Validation techniques employed for market sizing
Exhibit 82: List of abbreviations
Exhibit 83: Definition of market positioning of vendors


Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • MORE
The following companies are recognised as the key players in the global Influenza Diagnostics market: Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is increasing approvals of influenza diagnostic products by regulatory authorities.”

According to the report, one of the major drivers for this market is the increasing demand for point-of-care diagnostics.

Further, the report states that one of the major factors hindering the growth of this market is the lack of laboratory infrastructure in developing regions.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll